Skip to content
PreclinicalResearch compound

Adipotide (FTPP)

Pro-apoptotic peptide, adipocyte-specific fat reduction

Telegram
Adipotide (FTPP) vial

WHAT IS ADIPOTIDE (FTPP)?

Detailed overview

Adipotide (Prohibitin-targeting peptide-1) drives apoptosis of adipose-specific vasculature; preclinical models show major fat mass reduction.

Type

Pro-apoptotic peptide

Status

Preclinical / early human

Route

SC

Storage

2–8°C

Source

Placeholder, image later

Metabolic support

Glucose and lipid metabolism shift favorably: insulin sensitivity improves, glycemic swings and HbA1c drop, while LDL and triglycerides normalize. Body composition refines, fat mass decreases, lean mass is preserved or grows. Appetite is regulated both centrally and peripherally (GLP-1 / GIP / glucagon pathways), so caloric intake settles into a sustainable range without constant willpower. Energy expenditure and thermogenesis rise modestly.

Data console

Lab data

/lab/molecular-data.jsonLIVE
> ClassificationPro-apoptotic peptide
> StructureN/A
> Molecular weightN/A
> Target area-
> Storage2–8°C
> Stability~30 days reconstituted

Research indications

Investigated uses and mechanisms

Weight regulation

Reduced appetite and increased energy expenditure via GLP-1 / GIP / glucagon agonism.

Type 2 diabetes

Improved insulin sensitivity and HbA1c reduction in clinical trials.

Cardiometabolic profile

Favorable shifts in lipid profile and blood pressure.

Reconstitution

How to prepare, step by step

Important

Sterile technique required. Use bacteriostatic water (BAC) only. Never distilled or tap water.

  1. 01

    Remove the vial and bacteriostatic water (BAC) from refrigeration; let them reach room temp for 5 minutes.

  2. 02

    Wipe both vial stoppers with an alcohol swab.

  3. 03

    Draw 1 ml of BAC water into a sterile syringe (typical for the 2 mg vial).

  4. 04

    Inject slowly down the side of the vial, do NOT spray directly onto the peptide powder.

  5. 05

    Swirl gently in a circular motion until dissolved (~30 s), do not shake.

  6. 06

    Wait for the solution to become clear. If sediment or discoloration appears, discard it.

  7. 07

    Label the vial with reconstitution date and concentration.

  8. 08

    Store at 2–8 °C, protected from light. Inspect visually before each use.

Quality indicators

How to recognize a pure peptide

Purity markers

4

  • White / off-white powder

    Typical appearance of sterile lyophilized peptide.

  • Comes with COA (Certificate of Analysis)

    Independent lab analysis, ≥98% purity.

  • Intact, sealed vial

    Rubber stopper + aluminum crimp intact, ensuring sterility.

  • Dissolves clear

    Clear solution after reconstitution, no sediment.

Use caution

1

  • Storage temperature

    Extended room-temp exposure may reduce potency.

Do not use

2

  • Discoloration / sediment

    Yellow, cloudy or particulate solution, indicates degradation, do not use.

  • Damaged packaging

    Cracked vial or loose cap, sterility compromised, discard.

Interactions & stacks

What to combine and what to avoid

Retatrutide

Synergistic

Triple incretin agonist: metabolic health and weight loss

Tirzepatide

Synergistic

Dual GIP/GLP-1 agonist: weight & glucose control

Berberine

Synergistic

Insulin sensitivity + GLP-1 effects combine well.

Vitamin C / Zinc / B-complex

Synergistic

Supports collagen synthesis and antioxidant capacity.

Metformin

Complementary

Many clinical protocols combine them, supervision advised.

Caffeine

Requires timing

Compatible with morning dosing; avoid late-day stacking.

NSAIDs (Ibuprofen, ASA)

Use caution

Long-term concurrent use may blunt regenerative effects.

Alcohol

Avoid

Reduces recovery and increases side-effect risk.

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Nausea, headache, especially during titration
  • Appetite and bowel-motility shifts
  • Local skin reaction at injection site
  • Transient blood-sugar variability (esp. in diabetics)
  • Mild heart-rate increase

Contraindications · 5

  • Pregnancy and breastfeeding
  • Active malignancy
  • Known allergy to the peptide or its components
  • Severe hepatic or renal impairment (medical consultation required)
  • Age under 18

Related Peptides

Same therapeutic category

Telegram

Have a question about Adipotide (FTPP)?

Reach out to an advisor on Telegram. We can help you find the right peptide.

Telegram

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 2, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.